These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 10859040)
41. The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study. Walters MR; Kaste M; Lees KR; Diener HC; Hommel M; De Keyser J; Steiner H; Versavel M Cerebrovasc Dis; 2005; 20(5):304-9. PubMed ID: 16131799 [TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial. Liu X; Xia J; Wang L; Song Y; Yang J; Yan Y; Ren H; Zhao G Eur J Neurol; 2009 May; 16(5):569-75. PubMed ID: 19236467 [TBL] [Abstract][Full Text] [Related]
43. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451 [TBL] [Abstract][Full Text] [Related]
44. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia. Banks P; Franks NP; Dickinson R Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979 [TBL] [Abstract][Full Text] [Related]
46. Diazepam to improve acute stroke outcome: results of the early GABA-Ergic activation study in stroke trial. a randomized double-blind placebo-controlled trial. Lodder J; van Raak L; Hilton A; Hardy E; Kessels A; Cerebrovasc Dis; 2006; 21(1-2):120-7. PubMed ID: 16340187 [TBL] [Abstract][Full Text] [Related]
47. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z; Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884 [TBL] [Abstract][Full Text] [Related]
48. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial. Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW; Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644 [TBL] [Abstract][Full Text] [Related]
49. Effectiveness of high dose dexamethasone in the treatment of acute stroke. Ogun SA; Odusote KA West Afr J Med; 2001; 20(1):1-6. PubMed ID: 11505880 [TBL] [Abstract][Full Text] [Related]
52. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236 [TBL] [Abstract][Full Text] [Related]
53. Elevated pulse pressure during the acute period of ischemic stroke is associated with poor stroke outcome. Aslanyan S; Weir CJ; Lees KR; Stroke; 2004 Jun; 35(6):e153-5. PubMed ID: 15073388 [TBL] [Abstract][Full Text] [Related]
54. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. Saver JL; Starkman S; Eckstein M; Stratton SJ; Pratt FD; Hamilton S; Conwit R; Liebeskind DS; Sung G; Kramer I; Moreau G; Goldweber R; Sanossian N; N Engl J Med; 2015 Feb; 372(6):528-36. PubMed ID: 25651247 [TBL] [Abstract][Full Text] [Related]
55. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C; Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558 [TBL] [Abstract][Full Text] [Related]
56. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Middleton S; McElduff P; Ward J; Grimshaw JM; Dale S; D'Este C; Drury P; Griffiths R; Cheung NW; Quinn C; Evans M; Cadilhac D; Levi C; Lancet; 2011 Nov; 378(9804):1699-706. PubMed ID: 21996470 [TBL] [Abstract][Full Text] [Related]
57. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Lang W; Stadler CH; Poljakovic Z; Fleet D; Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193 [TBL] [Abstract][Full Text] [Related]
58. Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Liu X; Wang L; Wen A; Yang J; Yan Y; Song Y; Liu X; Ren H; Wu Y; Li Z; Chen W; Xu Y; Li L; Xia J; Zhao G Eur J Neurol; 2012 Jun; 19(6):855-63. PubMed ID: 22233205 [TBL] [Abstract][Full Text] [Related]
59. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms. Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718 [TBL] [Abstract][Full Text] [Related]
60. Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes. Ahmed N; Wahlgren NG Cerebrovasc Dis; 2003; 15(4):235-43. PubMed ID: 12686786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]